Research Areas

A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of an investigational medication Compared With Sulfonylurea Therapy in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Monotherapy

A Double-Blind, Randomized, Placebo Controlled, Dose Ranging Study to Assess the Tolerability, Pharmacokinetics, and Effects on a Hypoglycemic Challenge of Fourteen Days Multiple Dosing with an Investigational Medication in Subjects with Insulin Dependent Diabetes Mellitus

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Continuous Subcutaneous Infusion and Preprandial Bolus Doses of an Investigational Medication or Placebo on Plasma Glucose Profiles in Juvenile-Onset Diabetes

A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole XR (Extended Release) In Patients with Restless Legs Syndrome

Collection of normal blood samples for use in genetic studies for Colon Cancer

Pharmacogenomic Sample Collection from Subjects Experiencing Edema Secondary to Glitazone Therapy or Rhabdomyolysis/Severe Myalgia Secondary to Statin Therapy

Double-Blind, Parallel-Group, Randomized, Study of the Efficacy and Safety of Continuous Use of Celecoxib vs. the “Usual Use” of Celecoxib in the Treatment of Subjects with Chronic Osteoarthritis of the Hip or Knee Who Require An Anti-Inflammatory Medication for Control of the Their Pain

A Double-Masked, Double-Dummy, Randomized, Acyclovir Controlled, Parallel Group Study to Compare the Efficacy and Safety of an Investigational Medication with Acyclovir in the Treatment of Patients with Ophthalmic Zoster.

A Multi-Center, Double-Blind, Placebo-Controlled Group Comparison Study to Investigate the Efficacy, Tolerability and Safety of an Investigational Medication in Three Different Doses in the Treatment of Patients With Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Inadequately Controlled With Maximum Daily Doses of Sulfonylurea and Diet

A One-Year, Multicenter, Double-Blind, Randomized, Parallel Group Comparison Extension Study to Investigate the Long-Term Efficacy, Tolerability and Safety of an Investigational Medication As Compared to a Fixed Dose of Sulfonylurea, Alone and in Combination With an Investigational Medication, in the Treatment of Patients With Non-Insulin-Dependent Diabetes Mellitus (NIDDM) who Have Satisfactorily Completed The Double-blind Treatment Phase of Study

A Multi-Center, Double-Blind, Placebo-Controlled Group Comparison Study to Investigate the Efficacy, Tolerability and Safety of an Investigational Medication as Compared to a Fixed Dose of Sulfonylurea, Alone and in Combination With an Investigational Medication, in the Treatment of Patients With Mild Non-Insulin-Dependent Diabetes Mellitus (Type II) Inadequately Controlled With Diet Alone

A OneYear, Multicenter-Center, Double-Blind, Randomized, Parallel Group Comparison Extension Study To Investigate the Long-Term Efficacy, Tolerability and Safety of an Investigational Medication in Three Different Doses in the Treatment of Patients With Non-Insulin-Dependent Diabetes Mellitus (NIDDM) who Have Satisfactorily Completed The Double-blind Treatment Phase of Study

A Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of an investigational medication in Combination with Metformin and Pioglitazone to Metformin and Pioglitazone Alone in Insulin Naïve Subjects with Type 2 Diabetes

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of an investigation medication in Type 2 Diabetics with Inadequate Glycemic Control on Sulfonylurea Monotherapy or Sulfonylurea Therapy in Combination with Other Oral Anti-Diabetic Agents

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of an investigational medication to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of an investigational medication to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy

A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of an investigational medication to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Pioglitazone Therapy

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of an investigational medication Monotherapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

Standard Training versus Intensive Training for an investigational medication and device in Insulin-Naïve Patients with Type 2 Diabetes Mellitus

A Double Blind Dose-Ranging Study of an Investigational Medication taken Once Daily Compared to Placebo and to Lovastatin Taken Once Daily in Patients with Hypercholesterolemia